-
EP2555779
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2555779
| EP2555779 - GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.03.2018 Database last updated on 20.07.2024 | |
| Former | Examination is in progress Status updated on 30.06.2017 | Most recent event Tooltip | 23.03.2018 | Application deemed to be withdrawn | published on 25.04.2018 [2018/17] | Applicant(s) | For all designated states GlycoMimetics, Inc. 9708 Medical Center Drive Rockville, MD 20850 / US | [N/P] |
| Former [2017/33] | For all designated states GlycoMimetics, Inc. 9708 Medical Center Drive Rockville MD 20850 / US | ||
| Former [2013/07] | For all designated states GlycoMimetics, Inc. 401 Professional Drive Suite 250 Gaithersburg, MD 20879 / US | Inventor(s) | 01 /
MAGNANI, John, L. 12216 Triple Crown Road Gaithersburg Maryland 20878 / US | 02 /
SARKAR, Arun, K. 14110 Stonecutter Drive North Potomac Maryland 20878 / US | [2013/07] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [N/P] |
| Former [2013/07] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Leopoldstrasse 4 80802 München / DE | Application number, filing date | 11715140.7 | 06.04.2011 | WO2011US31428 | Priority number, date | US20100321740P | 07.04.2010 Original published format: US 321740 P | [2013/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011127179 | Date: | 13.10.2011 | Language: | EN | [2011/41] | Type: | A1 Application with search report | No.: | EP2555779 | Date: | 13.02.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.10.2011 takes the place of the publication of the European patent application. | [2013/07] | Search report(s) | International search report - published on: | EP | 13.10.2011 | Classification | IPC: | A61K31/715, A61K47/48, A61K31/7028, A61K31/7048, C07H15/207, A61P31/18 | [2013/07] | CPC: |
C07H15/207 (EP,US);
A61K47/55 (EP,US);
A61P31/18 (EP);
C07H15/26 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/07] | Title | German: | GLYCOMIMETISCHE VERBINDUNGEN UND VERFAHREN ZUR HEMMUNG VON HIV-INFEKTIONEN | [2013/07] | English: | GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV | [2013/07] | French: | COMPOSÉS GLYCOMIMÉTIQUES ET MÉTHODES D'INHIBITION D'UNE INFECTION PAR LE VIH | [2013/07] | Entry into regional phase | 07.11.2012 | National basic fee paid | 07.11.2012 | Designation fee(s) paid | 07.11.2012 | Examination fee paid | Examination procedure | 07.11.2012 | Examination requested [2013/07] | 31.05.2013 | Amendment by applicant (claims and/or description) | 03.07.2017 | Despatch of a communication from the examining division (Time limit: M04) | 14.11.2017 | Application deemed to be withdrawn, date of legal effect [2018/17] | 13.12.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/17] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 03.07.2017 | Fees paid | Renewal fee | 29.04.2013 | Renewal fee patent year 03 | 28.04.2014 | Renewal fee patent year 04 | 27.04.2015 | Renewal fee patent year 05 | 27.04.2016 | Renewal fee patent year 06 | 27.04.2017 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]EP0867722 (TAKARA SHUZO CO [JP]) [A] 1-22 * page 5, lines 42-50 * * fluorophores 3,5, 7; page 7, lines 51, 53, 55; example 1 * * page 10, lines 1-10; claims 1, 8-9 *; | [Y]WO2004033663 (UNIV MARYLAND BIOTECH INST [US], et al) [Y] 1-22 * the whole document * * figures 2, 5, 8, 11, 13, 15 * * claims 1-38 * * table; page 35 *; | [Y]WO2006017180 (PROGENICS PHARM INC [US], et al) [Y] 1-22 * claims 1-9 *; | [Y]WO2007033329 (UNIV MARYLAND BIOTECH INST [US], et al) [Y] 1-22 * claims 1-13 *; | [Y]US2007213278 (WONG CHI-HUEY [US], et al) [Y] 1-22 * the whole document *; | [Y] - ADAMS E W ET AL, "Oligosaccharide and Glycoprotein Microarrays as Tools in HIV Glycobiology", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 11, no. 6, doi:DOI:10.1016/J.CHEMBIOL.2004.04.010, ISSN 1074-5521, (20040601), pages 875 - 881, (20040625), XP025940209 [Y] 1-22 * the whole document * DOI: http://dx.doi.org/10.1016/j.chembiol.2004.04.010 | [A] - ERNST B ET AL, "From carbohydrate leads to glycomimetic drugs", NATURE REVIEWS DRUG DISCOVERY 2009 NATURE PUBLISHING GROUP GBR LNKD- DOI:10.1038/NRD2852, (2009), vol. 8, no. 8, ISSN 1474-1776, pages 661 - 677, XP007918904 [A] 1-22 * Passage with heading "DC-SIGN"; page 664 * * page 666; figure 2 * DOI: http://dx.doi.org/10.1038/nrd2852 | [YP] - OBERMAJER NATASA ET AL, "Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists", MOLECULAR DIVERSITY, (20101114), vol. 15, no. 2, Sp. Iss. SI, pages 347 - 360, XP007918908 [YP] 1-22 * the whole document * DOI: http://dx.doi.org/10.1007/s11030-010-9285-y | by applicant | - CARBOHYDR. RES., (1989), vol. 193, pages 283 - 287 | US20110321740 |